Naloxone is a medication that can reverse an overdose that is caused by an opioid drug (i.e., prescription pain medication, heroin, or illicit fentanyl). When administered during an overdose, naloxone blocks the effects of opioids on the brain and restores breathing within 2 to 3 minutes. Naloxone has been used safely by medical professionals for more than 40 years and has only one function: to reverse the effects of opioids on the brain and respiratory system in order to prevent death. As of August 1, 2023, the Food and Drug Administration (FDA) has approved three naloxone products for over the counter (OTC) use. As of September 2023, naloxone is now available over the counter. Products approved by the FDA for sale over the counter include:
- Narcan™ 4mg naloxone nasal spray, manufactured by Emergent BioSolutions
- Generic naloxone 4mg nasal sprays equivalent to the branded Narcan® spray, manufactured by multiple pharmaceutical companies
- RiVive™ 3mg naloxone nasal spray, manufactured by Harm Reduction Therapeutics
Availability of these products may vary by store.
Naloxone Frequently Asked Questions
Resources
Naloxone Standing Order for Public(opens in a new tab)
Naloxone Standing Order for First Responders(opens in a new tab)
Naloxone Training Video(opens in a new tab)
Naloxone Product Fact Sheet(opens in a new tab)
How to Use Naloxone Flyer(opens in a new tab)
How to Use Injection Naloxone Flyer(opens in a new tab)
How to Use Injection Naloxone Infographic(opens in a new tab)
Over the Counter Naloxone Flyer
PA Opioid Safety Focus On Naloxone(opens in a new tab)
Naloxone FAQ for Pharmacies(opens in a new tab)
Overdose: Recognize and Response Statewide Resource
If you would like to insert local information in the QR code area, please download this version.